Pbpk-pd modeling for the preclinical development and clinical translation of tau antibodies for alzheimer

HIGHLIGHTS

  • who: . et al. from the Applied BioMath, United States York University, United States have published the Article: PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer, in the Journal: (JOURNAL)
  • what: The aim of the research was to develop a mechanistic mathematical model to enhance the quantitative understanding for pharmacokinetics and pharmacodynamics of tau antibodies in animals and humans. For the study only one site was used for ISF collection.
  • how: The following target binding equations were introduced into the model to describe the interaction between antibody . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?